July 12, 2010
International forum for clever ideas: Fresenius Inventors' Fair launches its 11th running - Registration now open
Fresenius provides an incentive to inventors for what often is a long path from their initial flash of genius to ultimately achieving a marketable product. In this endeavor, the health care group aims to promote innovative developments within all medical sectors. For the event's 11th running, bright minds will be able to present their ingenuity during the Fresenius Inventors' Fair. The biennial event will be staged in conjunction with MEDICA 2010, the world's largest medical trade fair, held in Düsseldorf Nov. 17–20. The adjunct fair offers participating researchers, developers and inventors an international forum to attract the attention of potential business partners and investors for the marketing and advancement of their initial innovations up to market-ready products. The top three entries are chosen on the opening day of the MEDICA event by an independent jury comprised of medical specialists and business professionals. The Fresenius Inventors' Award carries cash prizes totaling €10,000. Above all, recognition is based on the criteria of potential usefulness, innovativeness and feasibility of being implemented. Registration of entries for the competition is now open.
An engineer hailing from Karlsruhe, Dr. Nicole Kikillus was the winner of the 2008 Fresenius Inventors' Award. She developed a particularly reliable method of detecting atrial fibrillation in patients, even if no such fibrillation occurs during a medical checkup. This condition is the leading clinical type of cardiac arrhythmia and increases the risk of stroke. Kikillus' software analyzes a 30- to 60-minute single-channel electrocardiogram, yielding an early diagnosis of atrial fibrillation patients and enabling therapy to reduce the chances of stroke.
As of immediately, physicians, researchers, engineers and other practitioners from the hospital field and medical care profession can submit their entries for consideration. Fresenius will provide winning entries display space and an exhibit booth at the fair free of charge. Selected from among numerous professionals from all medical fields who entered the previous competition, 20 such exhibitors presented their innovations at the 2008 Fresenius Inventors' Fair.
The deadline for competition entries is Oct. 1, 2010. Further details about the Fresenius Inventors' Fair can be found at www.fresenius.com/inventorsfair; and about the MEDICA event at www.medica-tradefair.com. Contact: Fresenius SE; Keyword: "Inventors' Fair", 61346 Bad Homburg, Telefax: +49 61 72 - 6 08 22 94, E-mail: daniela.hegemann@fresenius.com.
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care. In 2009, Group sales were approximately €14.2 billion. On March 31, 2010, the Fresenius Group had 132,242 employees worldwide.
For more information, visit the company's website at www.fresenius.com.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g., changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Board of Management: Dr. Ulf M. Schneider (President and CEO), Rainer Baule, Dr. Francesco De Meo, Dr. Jürgen Götz, Dr. Ben Lipps, Stephan Sturm, Dr. Ernst Wastler
Supervisory Board: Dr. Gerd Krick (Chairman)
Coporate Head Office: Bad Homburg, Germany
Commercial Register: Bad Homburg, HRB 10660